ClinicalTrials.Veeva

Menu
A

Anima Research Center | Alken, Belgium

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Semaglutide
E2086
BI 1569912
JZP-258
BI 690517
Elinzanetant
Vicadrostat
REGN5381
Empagliflozin

Parent organization

This site is a part of Anima Research Center

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 9 total trials

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

This clinical study is testing how the study medicine CagriSema helps people living with obesity, with or without type 2 diabetes (T2D), lose weight....

Enrolling
Obesity
Type 2 Diabetes
Drug: Cagrisema
Drug: Semaglutide

The primary purpose of this study is to evaluate the optimal doses of E2086 compared to placebo in participants with narcolepsy for reduction of exce...

Enrolling
Narcolepsy
Drug: E2086
Drug: Placebo

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these cond...

Enrolling
Hypertension
Cardiovascular Diseases
Drug: Placebo matching Vicadrostat
Drug: Vicadrostat
New

The purpose of this study is to see how oral semaglutide, when taken in lower doses help lowering of body weight in participants with excess body wei...

Enrolling
Overweight
Obesity
Drug: Placebo
Drug: Semaglutide

Trial sponsors

Boehringer Ingelheim logo
Novo Nordisk logo
Bayer logo
Eisai logo
Jazz Pharmaceuticals logo
Moderna logo
Regeneron Pharmaceuticals logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems